ECLCX
Price
$28.77
Change
-$0.64 (-2.18%)
Updated
Feb 21 closing price
Net Assets
437.68M
GFACX
Price
$65.66
Change
-$1.58 (-2.35%)
Updated
Feb 21 closing price
Net Assets
304.33B
Ad is loading...

ECLCX vs GFACX

Header iconECLCX vs GFACX Comparison
Open Charts ECLCX vs GFACXBanner chart's image
Eaton Vance Growth C
Price$28.77
Change-$0.64 (-2.18%)
VolumeN/A
Net Assets437.68M
American Funds Growth Fund of Amer C
Price$65.66
Change-$1.58 (-2.35%)
VolumeN/A
Net Assets304.33B
ECLCX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ECLCX vs. GFACX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ECLCX is a StrongBuy and GFACX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 304B vs. ECLCX (438M). ECLCX (0.00) and GFACX (0.00) have matching dividends . ECLCX was incepted earlier than GFACX: ECLCX (22 years) vs GFACX (24 years). GFACX is a more actively managed with annual turnover of: 31.00 vs. ECLCX (28.00). GFACX has a lower initial minimum investment than ECLCX: GFACX (250) vs ECLCX (1000). GFACX annual gain was more profitable for investors over the last year : 10.15 vs. ECLCX (8.85). GFACX return over 5 years is better than : 32.83 vs. ECLCX (19.78).
ECLCXGFACXECLCX / GFACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years24 years-
Gain YTD0.7712.98026%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets438M304B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year8.8510.1587%
Returns for 3 years11.5117.6965%
Returns for 5 years19.7832.8360%
Returns for 10 years42.5055.6376%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLN10.080.18
+1.82%
Haleon plc
SANM85.72-2.84
-3.21%
Sanmina Corp
HMST9.80-0.33
-3.26%
HomeStreet
ATNM1.17-0.06
-4.88%
Actinium Pharmaceuticals
EVEX4.17-0.33
-7.33%
Eve Holding